CClinicalTrials.gg
CompletedNCT03629366SERUpdated Sep 16, 2020

Supported Employment for Refugees

An interventional study of Supported Employment (SE) and Treatment as usual (TAU) in Refugees, sponsored by NORCE Norwegian Research Centre AS. Completed at 1 site in Norway. Per ClinicalTrials.gov, last updated 2020-09-16.

Sponsored by NORCE Norwegian Research Centre AS · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Registered 1 year 2 months after the study started (first participant enrolled May 2017, registered Jul 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Randomized
Sex
All
01

Study summary

Humanitarian crises related to the Syrian conflict have led to a large increase in refugees in Europe in the recent years. There is need for effective approaches to increase labor market participation among refugees, and to reduce the impact of unfavorable exclusion mechanisms among this group. The Supported Employment for Refugees (the SER-trial) is a randomized controlled trial investigating the effectiveness of Supported Employment (SE) for newly arrived refugees who are involved in the mandatory introduction program provided for all refugees in Norway. SE is an intervention that has proved effective in promoting competitive employment among patients with severe mental illness in over twenty international randomized controlled trials, and is currently being evaluated for various new patient groups in ongoing trials. The SER-trial is however the first trial to evaluate the effect of SE for the target group of refugees (who may or may not have mental illness).

02

Conditions studied

  • Refugees

Keywords

  • Refugees
  • Supported Employment
  • Individual Placement and Support
  • Employment
  • Vocational Rehabilitation
  • Mental Health
03

In context

Lead sponsor

NORCE Norwegian Research Centre AS is the lead sponsor of 23 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Refugees in the city of Bergen, Norway
  • Expressed desire to work
  • Able to have a simple conversation in Norwegian or English

Exclusion criteria

Exclusion Criteria:

  • No expressed desire to work
  • Unable to have a simple conversation in Norwegian or English
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
66 participants (actual)

Study arms

  • Experimental
    Supported Employment (SE)

    Follow-up with Supported Employment (SE), provided by a job specialist trained in the eight evidence-based principles of Individual Placement and Support (IPS). The SE intervention is provided in addition to the mandatory introduction program for refugees in Norway (treatment as usual).

    Behavioral: Supported Employment (SE)

  • Active comparator
    Treatment as usual (TAU)

    Follow-up with treatment as usual, which involves participation in the mandatory introduction program provided for all refugees in Norway. The program includes training in Norwegian language and culture, as well as the various traditional employment schemes offered by the Norwegian labor and welfare Administration.

    Behavioral: Treatment as usual (TAU)

Interventions

  • BehavioralSupported Employment (SE)

    Supported Employment

  • BehavioralTreatment as usual (TAU)

    Treatment as usual

06

What researchers measure

Primary outcomes

  1. Competitive employment (register data and log books)

    Competitive employment will be assessed using register data from the State Register of Employers and Employees. Analyses will be carried out using both intention-to-treat and per protocol analyses. For per protocol analyses, log books from the service providers in the intervention group will be used.

    Time frame: 12 months

Secondary outcomes

  1. Acculturation (survey data)

    Acculturation will be assessed using the Vancouver Index of Acculturation (VIA)

    Time frame: 12 months

  2. Psychological distress (survey data)

    Psychological distress will be assessed using the Hopkins Symptom Checklist-25 (HSCL-25)

    Time frame: 12 months

  3. Posttraumatic stress (survey data)

    Posttraumatic stress will be assessed using the PTSD Checklist for DSM-5 (PCL-5)

    Time frame: 12 months

  4. Global well-being (survey data)

    Global well-being will be assessed using a 10-point Cantril Ladder Scale

    Time frame: 12 months

  5. Health-related quality of life (survey data)

    Health-related quality of life will be assessed using the Euro-Qol Visual Analog Scale

    Time frame: 12 months

07

Study locations

1 site
  • NORCE Norwegian Research Centre
    Bergen, 5020, Norway
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 16, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03629366
Lead sponsor
NORCE Norwegian Research Centre AS
Collaborators
Norwegian Labour and Welfare Administration
Responsible party
Sponsor
First posted
Aug 14, 2018
Start date
May 1, 2017
Primary completion
Apr 30, 2020
Completion
May 30, 2020
Last update
Sep 16, 2020

Study contacts

Vigdis Sveinsdottir, PhD
principal investigator · NORCE Norwegian Research Centre
Tonje Fyhn
principal investigator · NORCE Norwegian Research Centre

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion